(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

FLEXIVARIANT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

FLEXIVARIANT

ST13

US500000079403327

Classe

1, 5, 9, 10

Pedido

79403327

Registro

7772940

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10

Data de depósito

28/02/2024

Data de registro

29/04/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/04/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

HALMEN, KATHERINE E

Unidade examinadora

M20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Nuclera Ltd

Representantes

Rebecca Liebowitz Venable LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical preparations for scientific purposes; chemical preparationsenzymesgene editing enzymesoligonucleotidesproteins for scientific and industrial purposes; genesDNA and RNA being nucleic acid sequences for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNAsynthetic RNA and synthetic genes being nucleic acid sequences for scientific and industrial purposes; synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicalsreagents and enzymes for use in the preparation and creation of synthetic DNAsynthetic RNAsynthetic genes being nucleic acid sequences for scientific and industrial purposes and synthetic proteins for scientific and industrial purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemicalbiological and biochemical reagents used for the synthesis of DNARNAoligonucleotidesgenes and proteins for scientific and industrial purposes; diagnostic reagentsfor scientific purposes in kit form; chemical reagent mixtures in kit formother than for medical or veterinary use; reagents for scientific and research use in scientific apparatus for chemical or biological analysis; reagents for scientific and research use in biological processingother than for medical or veterinary purposes; biochemical catalysts; catalysts for chemical and biochemical processes; biochemical preparations for scientific purposes; biological and biochemical reagentsalso in kit formfor scientific or medical research use; reagents for scientific purposes; reagents for scientific use; reagents for medical research use; reagents for research purposes; laboratory reagents for scientific use; biological preparations provided in kit form for use in industry and science; kits comprised of biological preparations for use in science in the field of synthetic biology; chemical reagents for non-medical purposes for manufacture of biological molecules

Classe 5

Biologicalchemical and biochemical reagentsDNA and RNA products being nucleic acid sequencesproteins and gene editing enzymesall for medical diagnostic use; synthetic proteinsall for medical diagnostic use; DNA and RNA products being nucleic acid sequences for medical use; therapeutic DNA and RNA products being nucleic acid sequences for medical use; diagnostic reagents for medical purposes for clinical or medical laboratory use; reagents for in-vitro laboratory use for medical purposes

Classe 9

Scientific laboratory apparatus and instrumentsscientific desktop instruments for DNARNAgene and protein synthesis for scientific use; scientific desktop instruments for DNARNAgene and protein synthesismicrofluidic devices; medical laboratory research instruments in the nature of desktop instrument cartridges for use in scientific apparatus in connection with DNARNAgenecell and protein synthesis and characterization instrumentsnamely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors in the nature of sensor chips for scientificresearch or industrial purposes in DNARNAgene and protein synthesis; biochips in the nature of microchips; scientific research and laboratory apparatusapparatus and instruments for amplifying DNA and RNAreactorsbioreactorslaboratory apparatus and instruments for amplifying DNA and RNA using thermocyclersnot for medical purposes; apparatus and instruments for synthesising DNA and RNAmicroarraysscientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbio sensorsbio-chipsnot for medical purposes; scientific research and laboratory apparatusapparatus and instruments for processing DNA and RNAnamely scientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbiosensorsbiochips; computer hardware; recorded computer softwaredownloadable computer software and bioinformatics software for use in DNARNAgene and protein synthesis in the fields of biotechnologydrug discovery and medical science

Classe 10

Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testing all for medical purposes; apparatus and instruments for DNA and RNA analysisDNA and RNA sequencing and protein synthesis in the nature of microfluidic chipsmicrofluidic cartridgeselectromechanical chipsbio sensorsbio-chips for medical and veterinary purposes; apparatus for DNARNAgene and protein synthesis in the nature of microfluidic chipsmicrofluidic cartridgeselectromechanical chipsbio sensorsbio-chips for medical and veterinary purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/01/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

27/01/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/12/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

23/11/2025

FIMP

FINAL DISPOSITION PROCESSED

23/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

29/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

29/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2025

PUBO

PUBLISHED FOR OPPOSITION

11/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/03/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/02/2025

RFNT

REFUSAL PROCESSED BY IB

12/10/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

25/09/2024

RFRR

REFUSAL PROCESSED BY MPU

24/09/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/09/2024

CNRT

NON-FINAL ACTION WRITTEN

20/09/2024

DOCK

ASSIGNED TO EXAMINER

16/09/2024

MAFR

APPLICATION FILING RECEIPT MAILED

04/09/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/09/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

29/08/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace FLEXIVARIANT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.